Clinical Research Institute | Texas Tech University Health Sciences Center
TTUHSC students walking through Lubbock campus courtyard.

CRI Staff Image 2024

Mission & Vision Statement

The mission of the Clinical Research Institute (CRI) is to promote and facilitate the conduct of clinical research for faculty and trainees while upholding the highest standards of excellence by assuring human subject investigation be performed ethically, responsibly, and professionally to contribute to the health sciences’ body of knowledge. The Vision of the CRI is to improve the quality of healthcare in Texas and beyond through clinical research activities.

Patient-Oriented Research

One of the driving factors of the TTUHSC Clinical Research Institute is promoting patient-orientated research. Our office is experienced in conducting Phase I through Phase IV pharmaceutical and device, industry-sponsored, as well as investigator-initiated research protocols. 

The CAlcium and VAsopressin following Injury Early Resuscitation (CAVALIER) trial

The Texas Tech University Health Sciences Center is conducting a research study that will look at whether calcium, vasopressin, or both early in the course of treatment would help severely injured patients that lose a lot of blood survive their injuries.

The CAlcium and VAsopressin following Injury Early Resuscitation (CAVALIER) trial will include approximately 1,050 people aged 18 to 90. Patients who have traumatic injuries with loss of blood may be enrolled by participating emergency medical personnel during their transportation to the hospital or after arrival to University Medical Center Hospital.

CAVALIER is an Exception from Informed Consent (EFIC) trial, meaning that, the trial requires performing a potentially life-saving intervention in people who are too injured to give permission. This study will look at treatment for patients who have a traumatic injury and have lost a lot of blood. These patients are too injured to give permission before receiving the study drug. Permission for continued participation will be obtained from patients once they are able, or from their family members, as soon as possible. For more information about CAVALIER or to complete an anonymous survey on your thoughts about this EFIC study, please visit here.

This research is supported by DoD contract W81XWH-16-D-0024 W81XWH-22-F-0118. Any opinions, findings and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the Department of the Army, Department of Defense, or the U.S. Government. For more information on Emergency Research and Exception From Informed Consent (EFIC), please visit here.

Volunteer

Want to help in the advancement of science? Learn how you can make a difference by volunteering in a clinical research study.

 

 

Got Questions?

We're here to help. Contact us if you have questions.

Clinical Research Institute
806.743.4217
clinicalresearch@ttuhsc.edu